Breaking News Instant updates and real-time market news.

APLS

Apellis

$25.92

0.46 (1.81%)

07:51
07/09/19
07/09
07:51
07/09/19
07:51

Oppenheimer bullish on Apellis, initiates with an Outperform

As previously reported, Oppenheimer analyst Justin Kim started coverage of Apellis with an Outperform rating and $52 price target. The analyst believes its lead asset APL-2 is well positioned to address the high unmet need in geographic atrophy where no treatment options currently exist, while also addressing deeper unmet need in a defined orphan blood disorder. With the Phase 3 PNH study fully enrolled and Phase 3 studies in GA enrolling this year, Kim anticipates the shares could re-rate favorably over the coming 12-18 months.

  • 30

    Jul

  • 09

    Sep

APLS Apellis
$25.92

0.46 (1.81%)

03/28/19
BARD
03/28/19
INITIATION
Target $45
BARD
Outperform
Apellis initiated with an Outperform at Baird
Baird started Apellis Pharmaceuticals with an Outperform rating and $45 price target.
03/28/19
BARD
03/28/19
INITIATION
Target $45
BARD
Outperform
Apellis initiated with an Outperform at Baird
Baird analyst Madhu Kumar initiated Apellis with an Outperform rating and a price target of $45. The analyst says the company's lead asset, complement C3 inhibitor APL-2, has the "potential to disrupt multiple diseases, including the ophthalmologic market of geographic atrophy and orphan disease market of paroxysmal nocturnal hemoglobinuria". Kumar sees Apellis' top-line data from the Phase 3 PEGASUS trial in paroxysmal nocturnal hemoglobinuria as a "key near-term catalyst" for its shares.
03/29/19
03/29/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Etsy (ETSY) initiated with a Perform at Oppenheimer. 2. Apellis (APLS) and uniQure (QURE) initiated with an Outperform at Baird. 3. BRT Apartments (BRT) initiated with a Buy at DA Davidson. 4. Lilis Energy (LLEX) initiated with an Equal Weight at Stephens. 5. Outfront Media (OUT) initiated with an Outperform at Oppenheimer. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/08/19
OPCO
07/08/19
INITIATION
Target $52
OPCO
Outperform
Apellis initiated with an Outperform at Oppenheimer
Oppenheimer analyst Justin Kim initiated Apellis with an Outperform rating and $52 price target.

TODAY'S FREE FLY STORIES

PPG

PPG

$116.49

-0.115 (-0.10%)

13:49
07/18/19
07/18
13:49
07/18/19
13:49
Hot Stocks
PPG says Q2 EPS impacted by lower global industrial production »

According to prepared…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 05

    Aug

ZBRA

Zebra Technologies

$180.92

-16.74 (-8.47%)

13:40
07/18/19
07/18
13:40
07/18/19
13:40
Options
Notable vol spike in Zebra Technologies as shares sell off »

Notable vol spike in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

TELL

Tellurian

$6.98

0.31 (4.65%)

13:40
07/18/19
07/18
13:40
07/18/19
13:40
Recommendations
Tellurian analyst commentary at Stifel »

Tellurian higher after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JLL

Jones Lang LaSalle

$140.05

0.585 (0.42%)

13:32
07/18/19
07/18
13:32
07/18/19
13:32
Conference/Events
Jones Lang LaSalle management to meet with Mizuho »

Meeting with EVP Monahan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 06

    Aug

  • 06

    Aug

GOSS

Gossamer Bio

$19.60

-0.48 (-2.39%)

13:30
07/18/19
07/18
13:30
07/18/19
13:30
Options
Gossamer Bio call volume spikes on November purchase wit shares at 52wk lows »

Gossamer Bio call volume…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:25
07/18/19
07/18
13:25
07/18/19
13:25
Conference/Events
Cowen healthcare/biotech analysts to hold an analyst/industry conference call »

Healthcare Technology…

PEP

PepsiCo

$132.17

-0.6 (-0.45%)

13:24
07/18/19
07/18
13:24
07/18/19
13:24
Periodicals
Breaking Periodicals news story on PepsiCo »

PepsiCo in talks to buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:20
07/18/19
07/18
13:20
07/18/19
13:20
General news
Treasury's $14 B 10-year TIPS sale was on the soft side »

Treasury's $14 B…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
07/18/19
07/18
13:17
07/18/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
07/18/19
07/18
13:16
07/18/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNIT

Uniti Group

$8.55

-0.03 (-0.35%)

13:15
07/18/19
07/18
13:15
07/18/19
13:15
Options
Uniti Group put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

13:09
07/18/19
07/18
13:09
07/18/19
13:09
General news
10-Yr TIPS Auction Coupon Rate data reported »

10-Yr TIPS Auction Coupon…

13:09
07/18/19
07/18
13:09
07/18/19
13:09
General news
10-Yr TIPS Auction Total Amount data reported »

10-Yr TIPS Auction Total…

TELL

Tellurian

$6.99

0.32 (4.80%)

13:05
07/18/19
07/18
13:05
07/18/19
13:05
Options
Tellurian call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:57
07/18/19
07/18
12:57
07/18/19
12:57
Conference/Events
Stephens architecture analysts to hold analyst/industry conference call nosymbol »

Analysts hold an…

EMR

Emerson

$64.26

-0.4 (-0.62%)

12:55
07/18/19
07/18
12:55
07/18/19
12:55
Options
Emerson put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 06

    Aug

  • 22

    Aug

  • 06

    Sep

12:45
07/18/19
07/18
12:45
07/18/19
12:45
General news
Treasury $14 B 10-year TIPS preview: the auction outlook is mixed. »

Treasury $14 B 10-year…

FB

Facebook

$200.15

-1.82 (-0.90%)

12:43
07/18/19
07/18
12:43
07/18/19
12:43
Periodicals
Instagram hiding 'likes' in more countries to ease pressure, Gadgets says »

Facebook's Instagram…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

DHR

Danaher

$141.79

2.19 (1.57%)

12:40
07/18/19
07/18
12:40
07/18/19
12:40
Recommendations
Danaher analyst commentary at Piper Jaffray »

Danaher price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 07

    Nov

AXP

American Express

$128.02

0.975 (0.77%)

, V

Visa

$179.16

(0.00%)

12:39
07/18/19
07/18
12:39
07/18/19
12:39
Earnings
Fly Intel: What to watch in credit card space earnings reports »

American Express (AXP),…

AXP

American Express

$128.02

0.975 (0.77%)

V

Visa

$179.16

(0.00%)

MA

MasterCard

$275.83

0.49 (0.18%)

UBER

Uber

$43.74

0.12 (0.28%)

LYFT

Lyft

$65.51

0.35 (0.54%)

WU

Western Union

$20.42

0.02 (0.10%)

BBVA

Banco Bilbao

$5.42

-0.055 (-1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 23

    Jul

  • 30

    Jul

  • 01

    Aug

  • 07

    Aug

  • 08

    Aug

  • 08

    Aug

  • 27

    Oct

  • 13

    Nov

BUD

AB InBev

$88.73

0.31 (0.35%)

, KKR

KKR

$25.38

-0.08 (-0.31%)

12:36
07/18/19
07/18
12:36
07/18/19
12:36
Periodicals
AB InBev weighs asset sales after calling off Asian IPO, WSJ reports »

Anheuser-Busch InBev…

BUD

AB InBev

$88.73

0.31 (0.35%)

KKR

KKR

$25.38

-0.08 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 25

    Jul

ESV

Ensco Rowan

$7.74

-0.16 (-2.03%)

12:35
07/18/19
07/18
12:35
07/18/19
12:35
Options
Ensco put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 27

    Aug

CHS

Chico's

$3.29

-0.13 (-3.80%)

12:34
07/18/19
07/18
12:34
07/18/19
12:34
Hot Stocks
Chico's FAS initiates Fort Myers lockdown after call over active shooter threat »

Chico's FAS issued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPE

Callon Petroleum

$4.87

-0.35 (-6.71%)

12:33
07/18/19
07/18
12:33
07/18/19
12:33
Conference/Events
Callon Petroleum management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 19

    Jul

  • 27

    Aug

BUD

AB InBev

$88.64

0.22 (0.25%)

12:29
07/18/19
07/18
12:29
07/18/19
12:29
Hot Stocks
Breaking Hot Stocks news story on AB InBev »

AB InBev up 1% to $89.30…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.